drugset / Trial / NCT01312909

Smoking Cessation Study In Healthy Adolescent Smokers

NCT01312909

Phase 4 Completed 312 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is designed to see if varenicline combined with age appropriate (adolescent) smoking cessation counseling will help teens quit smoking.

Timeline

Start
2011-04
Primary completion
2018-01
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 0.5 mg Oral
Subject Varenicline Small molecule 1 mg Oral

Indications

No indication recorded.